Abstract
Schistosomiasis remains an infrequent travel-related disease, mostly affecting returnees from Sub-Saharan Africa. The neglect of schistosomiasis research and development has consequences not only for endemic populations but also for travellers. Recent studies highlight deficits in clinical recognition, diagnostics and therapy of travel-related schistosomiasis, with significant morbidity, both acute and chronic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have